Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ahvaz Jundishapur University of Medical Sciences

Frequency of beta-Thalassemia or beta-Hemoglobinopathy Carriers Simultaneously Affected with alpha-Thalassemia in Iran

Alizadeh, S. and Bavarsad, M. S. and Dorgalaleh, A. and Khatib, Z. K. and Dargahi, H. and Nassiri, N. and Hamid, F. and Rahim, F. and Jaseb, K. and Saki, N. (2014) Frequency of beta-Thalassemia or beta-Hemoglobinopathy Carriers Simultaneously Affected with alpha-Thalassemia in Iran. Clinical Laboratory, 60 (6). pp. 941-949. ISSN 1433-6510

Full text not available from this repository.
Official URL: <Go to ISI>://WOS:000342857600009

Abstract

Background: beta-thalassemias are prevalent heritable single gene disorders affecting the quantity of the hemoglobin molecule. Rarely, a co-inheritance of these impairments with alpha-thalassemia and/or a hemoglobinopathy occurs and makes an important double heterozygote or homozygous state. Thus finding these cases is essential for genetic counseling. The present study aimed to identify the prevalence of coexistent alpha-thalassemia mutations, hemoglobinopathies, and beta-thalassemia determinants. Methods: This descriptive study was performed on 5760 patients. We used complete blood cell count, Hb electrophoresis, and HbA2 measurement for thalassemia carrier identification. Increased HbA2 (>= 3.5) is the standard diagnostic marker for beta-thalassemia, while normal HbA2 with low MCH and MCV can indicate an alpha-thalassemia carrier or atypical beta-thalassemia minor. Individuals with MCV < 80 fL, MCH < 27 pg, and hemoglobin < 15.3 g/dL in men or < 14 g/dL in women, were candidates for molecular thalassemia investigations. Patients with abnormal hemoglobin varieties in hemoglobin electrophoresis were referred to a genetics laboratory for hemoglobinopathy detection. Results: 141 subjects out of 5760 were affected by a and beta-thalassemia or a beta-hemoglobinopathy simultaneously, including: 13 (11.1) fetuses, 55 (38.2) male cases, and 73 (50.7) females. Among these 141 alpha-thalassemia patients, 92 cases (65.24) were beta-thalassemia carriers and 3 (2.12) were beta-thalassemia major, 43(30.49) had beta-hemoglobinopathies, and 3 cases (2.12) had co-inherited beta-thalassemia and variant hemoglobins. 31 P-gene mutations were observed in this population, the most common being HbS Cd6 (A > T) ( 24). These thalassemia determinants account for about 46 of all detected mutations. As for a-gene mutations, -3.7 detection was the most prevalent. Conclusions: The relatively high prevalence of co-inherited alpha-thalassemia and hemoglobinopathies among beta-thalassemia carriers indicates the importance of molecular analysis to diagnose these double heterozygous or sole homozygous cases for prenatal diagnostic purposes and putting forth strategies to prevent more complicated and dangerous combinations.

Item Type: Article
Keywords: beta-thalassemia alpha-thalassemia hemoglobinopathy population prevalence mutations province
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences
Depositing User: مهندس مهدی شریفی
Last Modified: 01 Jun 2018 11:26
URI: http://eprints.ajums.ac.ir/id/eprint/13517

Actions (login required)

View Item View Item